1. Home
  2. TRT vs CTXR Comparison

TRT vs CTXR Comparison

Compare TRT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRT
  • CTXR
  • Stock Information
  • Founded
  • TRT 1958
  • CTXR 2007
  • Country
  • TRT United States
  • CTXR United States
  • Employees
  • TRT N/A
  • CTXR 23
  • Industry
  • TRT Industrial Machinery/Components
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRT Technology
  • CTXR Health Care
  • Exchange
  • TRT Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • TRT 22.5M
  • CTXR 21.6M
  • IPO Year
  • TRT N/A
  • CTXR N/A
  • Fundamental
  • Price
  • TRT $5.22
  • CTXR $1.64
  • Analyst Decision
  • TRT
  • CTXR Strong Buy
  • Analyst Count
  • TRT 0
  • CTXR 3
  • Target Price
  • TRT N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • TRT 28.7K
  • CTXR 2.1M
  • Earning Date
  • TRT 05-13-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • TRT N/A
  • CTXR N/A
  • EPS Growth
  • TRT N/A
  • CTXR N/A
  • EPS
  • TRT 0.00
  • CTXR N/A
  • Revenue
  • TRT $35,548,000.00
  • CTXR N/A
  • Revenue This Year
  • TRT N/A
  • CTXR N/A
  • Revenue Next Year
  • TRT N/A
  • CTXR N/A
  • P/E Ratio
  • TRT $1,225.74
  • CTXR N/A
  • Revenue Growth
  • TRT N/A
  • CTXR N/A
  • 52 Week Low
  • TRT $4.62
  • CTXR $0.65
  • 52 Week High
  • TRT $7.88
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • TRT 46.96
  • CTXR 57.82
  • Support Level
  • TRT $5.21
  • CTXR $1.49
  • Resistance Level
  • TRT $5.76
  • CTXR $2.48
  • Average True Range (ATR)
  • TRT 0.31
  • CTXR 0.27
  • MACD
  • TRT -0.00
  • CTXR -0.02
  • Stochastic Oscillator
  • TRT 12.00
  • CTXR 40.53

About TRT Trio-Tech International

Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: